Company Profile | ![]() | 0-9 | ![]() | A | ![]() | B | ![]() | C | ![]() | D | ![]() | E | ![]() | F | ![]() | G | ![]() | H | ![]() | I | ![]() | J | ![]() | K | ![]() | L | ![]() | M | ![]() | N | ![]() | O | ![]() | P | ![]() | Q | ![]() | R | ![]() | S | ![]() | T | ![]() | U | ![]() | V | ![]() | W | ![]() | X | ![]() | Y | ![]() | Z |
WPP plc
(NYSE: WPP)
|
2:54 PM UTC, 04/24/25 | |||
---|---|---|---|---|
Last: $37.27 | Change: +0.81 | %Change: +2.22% | Volume: 72,526 |
10:58 AM EDT, 03/14/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were up sharply late Friday morning, rising 1.47% to 1,411.02 on the S&P Europe Select ADR Index. Despite the gain, the index is down 0.61% for the week.
From continental Europe, the gainers were led by 3D printer company Materialise (MTLS) and financial services company Banco Santander (SAN), which rose 4.5% and 4%, respectively. They were followed by financial services company Banco Bilbao Vizcaya Argentaria (BBVA) and internet advertising firm Criteo (CRTO), which increased 3.7% and 3.6%, respectively.
The decliners from continental Europe were led by biopharmaceutical companies DBV Technologies (DBVT) and Genfit (GNFT), which fell 8% and 1.4%, respectively. They were followed by accommodations booking site trivago (TRVG) and medical device maker EDAP TMS (EDAP), which were off 0.3% and 0.2%, respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Mereo BioPharma Group (MREO), which advanced 5.2% and 4.2%, respectively. They were followed by biopharmaceutical company Amarin (AMRN) and biotech firm Autolus Therapeutics (AUTL), which were up 3.8% and 2.6%, respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Verona Pharma (VRNA) and TC Biopharm (TCBP), which lost 3% and 2.4%, respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and communications company WPP (WPP), which were down 1.8% and 1.7%, respectively.
http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.